LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Athira Pharma (NASDAQ: ATHA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: SVP, Finance and Accounting
03/03/2025
Buy
$0.38
73,350
$28K
73,350
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: SVP, Finance and Accounting
03/03/2025
Buy
$0.38
58,500
$22K
58,500
NASDAQ ATHA Athira Pharma
CHURCH KEVIN / officer: CHIEF SCIENTIFIC OFFICER
03/03/2025
Buy
$0.38
87,845
$33K
87,845
NASDAQ ATHA Athira Pharma
Litton Mark James / director, officer: President and CEO
03/03/2025
Buy
$0.38
333,815
$126K
333,815
NASDAQ ATHA Athira Pharma
San Martin Javier / officer: CHIEF MEDICAL OFFICER
03/03/2025
Buy
$0.38
111,270
$42K
111,270
NASDAQ ATHA Athira Pharma
Worthington Mark / officer: General Counsel and CCO
03/03/2025
Buy
$0.38
85,895
$32K
85,895